Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma

doi:10.3748/wjg.v20.i3.745

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7291)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

496

WORD

248

HTML

3763

Figures (1-5)

267

Tables (1-5)

226

Sum=5000

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1126

Download

1165

Sum=2291

Jan 21, 2014 (publication date) through Dec 19, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 21, 2014; 20(3): 745-754
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.745

Table 5 Recurrence, progression, and survival after transarterial chemoembolization

Numbers of patients with recurrence	77 (59.70%)
Numbers of patients with progression	44 (34.10%)
Time to recurrence and progression¹	47.0 (4.6) and 77.3 (5.1)
1-yr recurrence and progression rate	33% and 22%
2-yr recurrence and progression rate	55% and 33%
3-yr recurrence and progression rate	61% and 39%
Recurrence-free survival¹	27.8 (29.2)
Progression-free survival¹	33.8 (30.6)

¹months, mean (SD).

Citation: Kim HC, Suk KT, Kim DJ, Yoon JH, Kim YS, Baik GH, Kim JB, Kim CH, Sung H, Choi JY, Han KH, Park SH. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. World J Gastroenterol 2014; 20(3): 745-754
URL: https://www.wjgnet.com/1007-9327/full/v20/i3/745.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i3.745